Servier

X ray illustration of a running person with pain in knee joint with blue background
Biotech

Novartis culls ph. 2 knee pain trial testing anti-ADAMTS-5 asset

Novartis discontinued the study after an interim analysis found an “insufficient effect on pain relief,” a spokesperson said.
Gabrielle Masson Apr 16, 2025 2:55pm
A series of dice with a bag on them illustrating cost cuts

Servier severing forces OPM to make 'drastic choices' to adapt

Apr 4, 2025 9:05am
Glowing puzzle piece fitting into puzzle

Servier pays $70M for Black Diamond's deprioritized cancer drug

Mar 19, 2025 7:53am
Photo of white clouds in a blue sky

Servier extends AI drug development pact with Google Cloud

Jan 16, 2025 9:11am
IBD

OSE's ulcerative colitis prospect improves symptoms in phase 2

Jul 24, 2024 8:23am
brain cancer glioma glioblastoma brain

ASCO: Servier finds survival benefit in difficult brain cancer

Jun 5, 2023 8:55am